Literature DB >> 9221329

Recommendations for follow-up of health-care workers after occupational exposure to hepatitis C virus.

.   

Abstract

Hepatitis C virus (HCV) infection is a major cause of chronic liver disease in the United States and worldwide. At least 85% of persons with HCV infection become chronically infected, and chronic liver disease with persistently elevated liver enzymes develops in approximately 70% of all HCV-infected persons. Persons with chronic hepatitis C are at risk for cirrhosis and primary hepatocellular carcinoma. Most HCV transmission is associated with direct percutaneous exposure to blood. Health-care workers (HCWs) are at occupational risk for acquiring this viral infection. However, no vaccine is available to prevent hepatitis C, and immune globulin is not recommended for postexposure prophylaxis.

Entities:  

Mesh:

Year:  1997        PMID: 9221329

Source DB:  PubMed          Journal:  MMWR Morb Mortal Wkly Rep        ISSN: 0149-2195            Impact factor:   17.586


  10 in total

1.  Evaluation of two different methods of arch bar application: a comparative prospective study.

Authors:  Naveen Chhabra; Shruti Chhabra; Deepti Thapar
Journal:  J Maxillofac Oral Surg       Date:  2014-07-18

2.  Hepatitis C virus: laboratory surveillance in England and Wales, 1992-2004.

Authors:  U Gungabissoon; M A Balogun; M E Ramsay
Journal:  Epidemiol Infect       Date:  2006-09-06       Impact factor: 2.451

Review 3.  Risk and management of blood-borne infections in health care workers.

Authors:  E M Beltrami; I T Williams; C N Shapiro; M E Chamberland
Journal:  Clin Microbiol Rev       Date:  2000-07       Impact factor: 26.132

Review 4.  Transmission and postexposure management of bloodborne virus infections in the health care setting: where are we now?

Authors:  B W Moloughney
Journal:  CMAJ       Date:  2001-08-21       Impact factor: 8.262

5.  [HCV, HBV and HIV infections: risk for surgeon and staff. Results and consequences of routine screening in emergency patients].

Authors:  K Dresing; C Pouwels; S Bonsack; M Oellerich; H Schwörer; A Uy; K M Stürmer
Journal:  Chirurg       Date:  2003-11       Impact factor: 0.955

6.  Case control study to identify risk factors for acute hepatitis C virus infection in Egypt.

Authors:  Amr M Kandeel; Maha Talaat; Salma A Afifi; Nasr M El-Sayed; Moustafa A Abdel Fadeel; Rana A Hajjeh; Frank J Mahoney
Journal:  BMC Infect Dis       Date:  2012-11-12       Impact factor: 3.090

Review 7.  Hepatitis C virus: Screening, diagnosis, and interpretation of laboratory assays.

Authors:  Ekta Gupta; Meenu Bajpai; Aashish Choudhary
Journal:  Asian J Transfus Sci       Date:  2014-01

8.  HCV elimination among people who inject drugs. Modelling pre- and post-WHO elimination era.

Authors:  Ilias Gountas; Vana Sypsa; Sarah Blach; Homie Razavi; Angelos Hatzakis
Journal:  PLoS One       Date:  2018-08-16       Impact factor: 3.240

9.  Hepatitis C virus modelled as an indirectly transmitted infection highlights the centrality of injection drug equipment in disease dynamics.

Authors:  Miles D Miller-Dickson; Victor A Meszaros; Salvador Almagro-Moreno; C Brandon Ogbunugafor
Journal:  J R Soc Interface       Date:  2019-09-04       Impact factor: 4.118

10.  A tailored health surveillance program unveils a case of MALT lymphoma in an HCV-positive health-care worker.

Authors:  Venerando Rapisarda; Andrea Marconi; Saverio Candido; Daria Nicolosi; Mario Salmeri; Pietro Gangemi; Lidia Proietti; Demetrios A Spandidos; Massimo Bracci; Cettina Fenga; Massimo Libra
Journal:  Oncol Lett       Date:  2012-11-15       Impact factor: 2.967

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.